Introduction
============

Genome Editing for targeted gene improvement is widely used in the field of plant science for basic research as well as for specific improvement of desired traits in commercial crops. Mainly five tools have been used for targeted Genome Editing so far. Besides Oligonucleotide Directed Mutagenesis (ODM), which had its origin in the early 80s of the last century and found its way in plant science ∼15 years ago, mainly engineered nuclease (ENs) are used ([@B61]). There are four kinds of engineered nucleases (i) Zinc-Finger Nucleases, (ii) Meganucleases (iii) Transcription Activator Like Effector Nucleases (TALENs) and (iv) Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)-Systems. The latter is more a collection of different closely related techniques which all have been adapted for the use in Genome Editing ([@B45]). Nowadays, most applications in plants (and in animals) are done by using either TALENs or CRISPR-Systems. In the majority of cases plants are stable transformed to introduce the Genome Editing tools into the plant genome (Figure [1A](#F1){ref-type="fig"}). Subsequently the plants are self-pollinated or crossed to get rid of the incorporated DNA, only the intended mutation remains. In some cases, transient expression of the tools e.g., via plasmids, initiate these mutations but all of these techniques make use of recombinant DNA at least in an intermediate step. Lately tools have been developed using solely RNA, preassembled Cas9 protein-gRNA ribonucleoproteins (RNPs) or TALEN-proteins for mutation induction (Figure [1B](#F1){ref-type="fig"}). All of these are completely free of DNA so the risk of DNA integration into the genome can be excluded. Due to this we will focus on these in the following article.

![Exemplary comparison of classic CRISPR/Cas9 and DNA-free CRISPR/Cas9. Comparison of classic CRISPR/Cas9 through the example of **(A)**. tumefaciens transformation and DNA-free CRISPR/Cas9 exemplified by PEG mediated protoplast fusion. **(A)** In the classic CRISPR/Cas9 technique a T-Plasmid is designed that includes the desired gRNA and Cas9 coding sequences. Via Agrobacterium tumefaciens mediated transfer both gRNA and Cas9 sequences can be integrated in the host genome. *In vivo* gRNA and Cas9 are translated and the gRNA-Cas9 RNP complex is formed. Upon target detection, a double strand break is induced and mutations can arise by internal cell repair mechanisms. The CRISPR/Cas9 complex is constantly expressed and active in the cell. Finally, the genome can contain both the desired mutation and sequences for gRNA and Cas9. The transgene can be outcrossed but this is less practical or even impossible in vegetative propagated crops. **(B)** For DNA-free CRISPR/Cas9 recombinant Cas9 and *in vitro* translated gRNA are required. The RNP complex is formed *in vitro* and is directly delivered to protoplasts by e.g., PEG fusion. The complex is already active and can directly detect its target to induce double strand breaks. Cell repair mechanisms can lead to a mutated genome at the desired target without addition of any foreign DNA. The CRISPR/Cas9 complex is degraded within the cell and no longer available.](fpls-09-01957-g001){#F1}

Targeted Nucleases
==================

Bacteria have been altering genomes since ages by using e.g., TALEs or CRISPR in combination with CRISPR associated (Cas) nucleases or other techniques such as classical restriction enzymes or Meganucleases ([@B47]; [@B30]; [@B54]; [@B48]). The aims of the bacteria using site-directed nucleases (SDNs) as tools are as diverse as ours, by using altered versions of these natural occurring mechanisms. TALEs e.g., have their origin in *Xanthomonas spec*. which manipulate cellular processes of the host by introducing TALE-proteins into plant cells via a type III secretion system ([@B22]). Once recognized their target, TALEs alter gene expression e.g., for sugar transporters to supply the bacteria with enough resources to grow which is triggering an infection in the host such as bacterial blight ([@B33]). Scientist revealed the hidden code of these natural occurring tracing devices and fused them with a nuclease (FokI) creating TALE-Nucleases (TALENs) ([@B7]; [@B9]). By using them as pairs a precise induction of a DNA double strand break is possible in many organisms ([@B52]).

CRISPR-Systems have a different origin and are ubiquitously present. Around 40% of bacteria *spec*. and 90% of archaea *spec*. sequenced so far possess one or more CRISPR-Systems ([@B40]; [@B51]). They have been described first by [@B29] in the model organism *Escherichia coli* but it took additional 30 years until their function as a kind of adaptive immune system of bacteria against invading nucleic acids such as plasmids or phages have been revealed in bacteria for yogurt production ([@B29]; [@B6]). Today CRISPR is still used in dairy industry to prevent phage infection in starter cultures ([@B24]). Additional applications have been derived from this mechanism, [@B31] described the ability of this technology for precise RNA guided genome modification and started the CRISPR-era ([@B31]). Their ideas have been adopted by many scientists working in various fields and led to a new age of Genome Editing. Till now hundreds of genomes have been edited in all kinds of kingdoms and clades ranging from small viruses to trees such as Poplar ([@B17]; [@B64]).

Besides the classical Cas9-System from *Streptococcus pyogenes* several Cas-variants from different species like *S.aureus*, *S.thermophilus* and others have been used for Genome Editing in plants ([@B53]; [@B14]). The classical Cas9 System consists of a dual RNA-complex, CRISPR (cr) RNA and *trans* activating CRISPR (tracr) RNA. [@B31]., fused these two RNAs for easier cloning and handling, creating the single guide RNA (sgRNA), for which multiple vector systems are currently available.

Other systems like the CRISPR/Cpf1 (Clustered Regularly Interspaced Short Palindromic Repeats from *Prevotella and Francisella*), recently named Cas12a, differ in several aspects from the classical CRISPR/Cas-Systems as (i) the nucleases are smaller (135 vs. 158 kDa) (ii) the systems possess a natural occurring single guide RNA (iii) cutting of Cas12a results in staggered cuts Cas9 cutting in blunt (iv) the Protospacer adjacent motifs has to be rich in thymine for Cas12a and rich in guanin for Cas9 and (v) the DNA is cut distal from the recognition site by Cas12a and proximal by Cas9.

Cas13 a CRISPR-variant which is able to recognize and cut specific RNA instead of DNA has recently been exploited for RNA editing and tracking in bacteria, mammals and also plants (review [@B2]). But additional studies have to be performed to test this system for commercial applications. It offers great potential for medicine as well as for agriculture. An initial study in bacterial cells showed non-target, collateral RNA degradation, but these effects have not been reported for recent studies performed in plants and mammals ([@B12]; [@B3]).

Current Applications
====================

Currently in several publications' authors promote their work as transgene-free but by taking a closer look at these publications reveal that the status of transgene-freeness focuses only on the end product. In many cases the mutation has been initiated by transient expression of plasmid based CRISPR-DNA or stable integration with subsequent backcrossing. For both techniques, integration of DNA into the host genome is still possible as plasmids are degraded in the cells and could integrate into cut sites ([@B62]). In this paper we focus on work which has been performed completely without the use of DNA for mutation initiation, meaning either RNA, RGEN RNPs or TALEN- proteins have been used for mutation induction. All of these techniques have been used successfully in plants. DNA-free editing has its origin in editing of animal cell lines or embryos where it is frequently used and is being adapted for more and more species ([@B28]; [@B44]). DNA-free editing of plants is a new but emerging field which arose 2015, as concerns raised that plants transformed using DNA might be covered by gene technology laws. To date, DNA-free editing is used in at least 14 plant species, to test the ability in proof of concept studies or for improvement of yield or tolerance against biotic and abiotic stress (Table [1](#T1){ref-type="table"}). The system is especially useful for species which propagate vegetative or have a long generation cycle as backcrossing is time consuming or impossible such as for potato, grapevine and apple (Table [1](#T1){ref-type="table"}; [@B39]; [@B4]).

###### 

Recent publications using DNA-free Genome Editing approaches.

  Reference   Plant species                                                                   Trait                                 GE-technique                            Tissue                          Delivery                 Editing efficiency                                                                                                                    Off-targets       Method
  ----------- ------------------------------------------------------------------------------- ------------------------------------- --------------------------------------- ------------------------------- ------------------------ ------------------------------------------------------------------------------------------------------------------------------------- ----------------- --------------------
  [@B62]      *Arabidopsis thaliana*, *Lactuca sativa*, *Nicotiana attenuata, Oryza sativa*   POC                                   CRISPR/Cas9 RNPs                        Protoplasts                     PEG-fusion               Calli: Monoallelic mutations: 5.7%; Biallelic mutations: 40%                                                                          0/104 (2--5 MM)   Targeted deep seq.
  [@B5]       *Chlamydomonas reinhardtii*                                                     Yield, abiotic stress                 CRISPR/Cas9 RNPs                        Single cells                    Electroporation          Cells: Up to 0.56%                                                                                                                    0/17 (2--4 MM)    Targeted deep seq.
  [@B39]      *Malus domestica*, *Vitis vinifera*                                             Biotic stress                         CRISPR/Cas9 RNPs                        Protoplasts                     PEG-fusion               Protoplasts: 0.1--6.9%                                                                                                                n.d.              n.d.
  [@B55]      *Nicotiana benthamiana*                                                         POC, herbicide resistance             TALEN mRNA                              Protoplasts                     PEG-fusion               Protoplasts: No-UTR DNA control: 70.5%, No-UTR mRNA control: 5.8%                                                                     n.d.              n.d.
  [@B50]      *C. reinhardtii*                                                                POC                                   CRISPR/Cas9 RNPs                        Single cells                    Electroporation          Up to 3 × 10^-5^                                                                                                                      0/333 (1--3 MM)   WGS
  [@B57]      Zea mays                                                                        Male sterility, herbicide tolerance   CRISPR/Cas9 RNPs                        Immature embryos                Biolistics               Embryo: Cas9 only: 0.002--0.02 DNA delivery: 0.18--0.56 RNP delivery: 0.01--0.69                                                      n.d.              n.d.
  [@B56]      Petunia hybrid                                                                  Herbicide resistance                  CRISPR/Cas9 RNPs                        Protoplasts                     PEG-fusion;              Protoplasts: Cas9 protein: 0.03--27.13, NR-RGEN: 5.3--34.69                                                                           n.d.              n.d.
  [@B65]      *Triticum aestivum*                                                             Yield                                 CRISPR/Cas9 mRNA                        immature embryos                Biolistics               No. of transgen-free frequency: 0--100% No. of homozygous transgen-free frequency: 0--36.8%                                           0/8 (2--4 MM)     PCR- RE
  [@B20]      *C. reinhardtii*                                                                POC, Gene replacement                 CRISPR/Cpf1 RNPs                        Single cells                    Electroporation          Colonies: 0.12--16%                                                                                                                   n.d.              n.d.
  [@B23]      Non-albicans candida                                                            POC                                   CRISPR/Cas9 RNPs                        Single cells                    Electroporation          n.d.                                                                                                                                  n.d.              n.d.
  [@B32]      Glycine max, *N. attenuata*                                                     Fat-synthesis; POC                    CRISPR/Cpf1 RNPs                        Protoplasts                     PEG-fusion               Soybean: Protoplasts: LbCpf1: 0--11.7% AsCpf1: 0--1.6% Tobacco: LbCpf1 and AsCpf1: \< 0.1% LbCpf1 + crRNA and AsCpf1 + crRNA: \< 1%   0/23 (4--6 MM)    Targeted deep seq.
  [@B35]      *T. aestivum*                                                                   Yield                                 CRISPR/Cas9 RNPs                        Protoplasts; immature embryos   PEG fusion, Biolistics   Protoplasts: 33.4 and 21.8% Embryo cells: gw2-RNPs: 0.18--0.21% pGE-TaGW2: 0.99--1% gasr7-RNP: 45.3%                                  0/20 (2--5 MM)    Sanger seq.
  [@B4]       *Solanum tuberosum*                                                             Starch syntheses                      CRISPR/Cas9 RNPs                        Protoplasts                     PEG-fusion               Protoplasts: 1--25%                                                                                                                   n.d.              n.d.
  [@B36]      *T. aestivum*, *O. sativa*                                                      Yield/ POC                            CRISPR/Cas9/Cpf1 RNPs, TALEN-Proteins   Protoplasts; immature embryos   PEG fusion, Biolistics   Protoplasts: 10.9--33.6%                                                                                                              n.d.              n.d.

GE-Technique, Genome editing technique; RNPs, Ribonucleoproteins; WGS, Whole Genome sequencing; POC, Proof of concept; n.d., not determined.

Besides the elimination of DNA integration which circumvents the need for backcrossing and screening of the progeny, the DNA-free systems offer some additional advantages compared to the DNA-based systems as till now no off-target effects (non-target cutting) have been observed neither using targeted nor untargeted approaches for identification ([@B5]; [@B50]; [@B32]). Further advantages are that (i) it can be used without further adaption in a majority of species (even those without established genomic alteration systems) as no coding sequence or promotor have to be adapted ([@B23]) (ii) the amount of editors can be controlled in a better way as promotor efficiency is avoided, (iii) the editors are ready to introduce mutations directly after transfection (no lagging phase). Most of these effects seems to be a result of the defined relatively short (∼48 h) persistence of the tools in the targeted organism.

But the systems also have to deal with some drawbacks as to date it is not possible to use it in all species, mainly due to undeveloped or unsuited *in vitro* techniques. Furthermore, the efficiency is lower compared to classical methods and a selection of positively edited plants is only possible by genomic selection such as sequencing. These points result in higher costs for the technique, but further optimization will result in better *in vitro* protocols and dropping costs.

Transformation Methods
======================

DNA-free Genome Editing is currently performed using CRISPR/Cas9 and TALENs and reagents are introduced by either transient expression of mRNAs encoding for TALENs or Cas nuclease and guide RNA or by direct delivery of isolated RNPs. When using RNPs the complex is already preassembled and active upon delivery, when using RNA, the editors have to be transcribed and the complex has to assemble which result in a short delay in activity. DNA-free transformation challenges two major problems: (i) Delivery through the plant cell wall and (ii) regeneration of plants from tissue or cell-wall free cells. To avoid the plant cell wall barrier most edits, use isolated protoplasts, single plant cells which cell wall has been enzymatic digested. Protoplasts were the first tissue which has been used for DNA-free Genome Editing as they can be targeted easily by polyethylene glycol (PEG) mediated fusion. Therefore, the RNP complex or mRNA is enclosed in PEG vesicles and fused with protoplasts. This system enables an average editing rate of around 10% which is lower compared to DNA-based systems ([@B57]; [@B4]). In potato the system is efficient from the transfection to regenerated plants, it was possible to alter all four copies of a single gene in 2--3% of the regenerated shoots ([@B4]). In other crops such as apple or grapevine the transformation system is working but regeneration protocols for edited lines are still not available as protoplast regeneration and identification of successfully modified lines is tricky and differ even between cultivars of the same species ([@B39]). The single-cell alga *Chlamydomonas reinhardtii* was successfully transformed with RNPs by electroporation. Although, functional protocols are available for potatoes, lettuce, tobacco, soy and petunia regeneration rate is often low ([@B62]; [@B56]; [@B32]). Lately also immature embryos are being used for DNA-free transformation systems. Immature embryos can be target by biolistic delivery of both RNPs and mRNA ([@B57]; [@B65]; [@B35]).

More methods are available to transfer naked DNA to plants but need to be adapted to transform DNA-free Genome Editing tools. Protoplast microinjection is described since 1983 ([@B25]) and has recently been relighted for DNA delivery in oil palm ([@B42]) but have not been tested for RNP delivery so far. An optimization of biolistic delivery to plant cells where proteins are loaded into the pores of gold activated mesoporous silica nanoparticles has been described ([@B41]) but not published for Genome Editing yet. To overcome regeneration of immature cells *in planta* particle bombardement (iPB) that targets mature plant tissue was introduced in wheat ([@B26]). A new method for the transformation of mature plant tissue is infiltration with cell penetrating peptides (CPPs). CPPs are a class of short, positively charged peptides that can translocate across cellular membranes. Recently they have been shown to be capable of binding site-specific nucleases ([@B46]). Still their potential for DNA-free Genome Editing in plants needs to be exploited.

Additional methods have also been tested to porate single cells and deliver macromolecules to the cell, such as microfluidic cell deformation or sonication and furthermore such as intensive light beams are being discussed but haven't been tested for plants so far ([@B27]; [@B49]).

The field of DNA-free Genome Editing is still evolving and besides new delivery methods for the reagents, proteins coupled to engineered nucleases are being developed. These approaches have been tested and used in stable transformation systems but seem to be also suitable for a DNA-free approach. Besides additional Cas-systems such as Cas12a from different organism also Cas13a could be adapted for a transient RNA-editing in an DNA-free approach, leading to a transient change in expression. This is comparable to the coupling of TALEs and other activators or repressors to Cas9 to alter the expression of genes for a defined time. Furthermore, nickases are frequently used to introduce single stranded DNA breaks in plants, to enhance specificity of Cas-systems ([@B18]). Due to the already high specificity of the DNA-free systems, nickases are not expected to be used in DNA-free approaches. Likely, other systems will be used in the near future e.g., base editors such as cytidine or adenosine deaminases, which have been used in plants already and offer great potential to be adopted for DNA-free approaches ([@B21]; [@B66]). A new and highly discussed approach is to alter methylation or acetylation for Epigenome Editing, these approaches could also be used in DNA-free approaches ([@B38]). The newest development in the field is the guidance of integrases by Cas9, to achieve a targeted recombination. This approach is still depended on integrase sites and has been tested only in yeast and mammalian cells but an intensive search for altered integrase sites is ongoing, so that in the future targeted recombination might be possible even in plants ([@B10]; [@B43]).

Regulatory Concepts and Concerns
================================

Although several European authorities proposed ways, how to handle and interpret new plant breeding technologies in the current or an updated European legal framework (e.g., [@B1]; [@B58]; [@B11]; [@B19]) the European court of justice (ECJ) decided fairly unscientifically on July 25th this year, that plant products derived from Genome Editing processes (other than modified by chemical or physical mutagenesis) fall under the strict regulatory framework applied for GMOs (ECLI:EU:C:2018:583)^[1](#fn01){ref-type="fn"}^. The judgment triggered strong displeasure in the European scientific community, who forecasts noticeable economic disadvantages for European plant- and seed industry ([@B15]; [@B16]; [@B60]). Additionally, also the Scientific advise mechanism of the European commission published a statement on the ruling in which they recall the product-based aspects of the European gene technology law and recommend "*revising the existing GMO Directive to reflect current knowledge and scientific evidence, in particular on gene editing and established techniques of genetic modification*" ([@B59]). Due to the ruling European plant breeders need to undergo expensive and time-consuming approval procedures before their products improved by GEENs can be placed on the market. In particular, for DNA-free Genome Editing approaches, this regulation is intangible due to the lacking difference to a conventionally bred plant, as no DNA from non-related crops or organisms is introduced into the plant genome and detectable, neither in the final plant product, nor in its progenies. At no time-point during generation process, the plant genome encounters foreign, recombinant DNA, which usually triggers current European GMO-regulations. The genome edits are usually indistinguishable from natural mutations ([@B8]). In addition, off-targets play a minor role in DNA-free approaches: compared with stable and transient expression, GEENs are degraded within hours and thus the GEEN's mode of action is only present in the original cells (protoplasts) of the edited plant ([@B34]). However, as long Europe sets its focus on the generation process during approval of new plant products, also DNA-free genome edited plants will fall within the same scrutiny as the few legal GMO-plants grown in Europe. This could lead to potential trade issues and impede innovation as stated by members of the WTO lately ([@B63]).

Notwithstanding, several countries started to update their legal interpretation of GEEN. Among them are the South-American ABC: Argentina, Brazil, Chile - the United States, Canada and Israel while in Japan and Australia new regulations and a possible exemption of Genome Editing approaches from strict rulings adopted for conventional genetically modified plants are still under discussion. Giving rise to a worldwide regulatory patchwork for genome-edited plants with a diverse set of interpretations and definitions for genome-edited plants resulting in reservations between international trade partners and trade restraints between economic regions. International harmonization of regulations and definitions thus is essential to close the risk-benefit gap between precaution and innovation potential of genome edited plants ([@B13]). Argentina pioneered with a straightforward regulation for the new Genome Editing technologies already in 2015, 2 years after the first application of CRISPR in plants. The Resolución 173/2015^[2](#fn02){ref-type="fn"}^ defines a case-by-case dependent approach, in which applicants can request the responsive authority CONABIA already during product development to determine if their products will fall under GMO regulation. Following the Cartagena protocol definitions for living modified organisms; this is only the case when the new plant product contains a **[-novel-]{.ul}** combination of genetic material -- similar to conventional transgenic approaches when a transgene is permanently detectable in the final plant product. In case of SDN-1 (NHEJ based deletion/change of a few, often less than 20 nucleotides ([@B37]) DNA-free Genome Editing approaches act without introducing foreign DNA that would be detectable in the final plant product. SDN-2 approaches (HDR based replacement of usually less than 20 nucleotides) using a short repair DNA sequence as template, are accordingly not completely DNA-free, although in the final plant product the template is not traceable anymore. In Argentina, plant products derived from GEENs thus will become less strictly regulated than classical GMOs. Likewise, similar guidelines are expectable in Brazil and Chile, which subsequently introduced similar case-by-case, mainly product-focused regulations. Brazil for example interprets GEENs explicitly as SDN as one of several "new precision breeding innovation technologies," which may create a product not considered a GMO in the annex I of the normative resolution no. 16/2018^[3](#fn03){ref-type="fn"}^. Recently, together with the former mentioned ABC, also Paraguay and Uruguay declared their intention to harmonize their Genome Editing-friendly regulations and to establish genome-edited plants analogous to conventionally bred plants^[4](#fn04){ref-type="fn"}^. This initiative will transform South America into a hot spot for further Genome Editing innovations. Plant products derived by GEENs still lack on the market in these countries, but it is commendable that more and more countries worldwide clarify their legal status to pave the way for the next green revolution.
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